Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,827.60
(
-0.49%
)
Dow Jones
49,447.43
(
1.79%
)
Brent Oil
91.42
(
-1.34%
)
Bitcoin
75,088.50
(
1.64%
)
News Focus
News Focus
Post# of 821994
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

attilathehunt

Send PM Follow Ignore
Followers 71
Posts 8981
Boards Moderated 0
Alias Born 03/06/2016

attilathehunt

Re: GoodGuyBill post# 756014

Monday, 03/24/2025 10:17:11 AM

Monday, March 24, 2025 10:17:11 AM

Post# of 821994

If Merck were to acquire NWBO and gain exclusive rights to DCVax-L, they could potentially create and market a combination therapy like "Keytruda+" that integrates DCVax-L with Keytruda



True, however Merck's only option currently is way of franchise. This may change with approval.

......Merck doesn't like the franchise route so there may be a very high offer to hostile buy outright upon approval . Merck doesn't like the franchise route (they do not want the competition).

Lets get approval and then on with the show!!!!!!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News